Facing Copaxone rivals, Teva looks to buy - FiercePharma
Links shared publicly online about this topic.
- 519total visits
Facing Copaxone rivals, Teva looks to buy - FiercePharma
Teva Pharmaceutical Industries ($TEVA) has some ambitious growth goals for 2015. And the way its multiple sclerosis drug Copaxone is growing, those ambitions appear more reasonable. But as Bloomberg... Read more...
View full resource at fiercepharma.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Pharma, Copaxone, Teva Pharmaceutical Industries
Most Recently Shared on February 9, 2011 at 3:42 pm By:
Facing Copaxone rivals, Teva looks to buy. http://bit.ly/g0OLNM
Advertisement
